145 related articles for article (PubMed ID: 35733806)
1. Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease.
Mosca A; Mantovani A; Crudele A; Panera N; Comparcola D; De Vito R; Bianchi M; Byrne CD; Targher G; Alisi A
Front Pediatr; 2022; 10():917714. PubMed ID: 35733806
[TBL] [Abstract][Full Text] [Related]
2. Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease.
Mosca A; Comparcola D; Romito I; Mantovani A; Nobili V; Byrne CD; Alisi A; Targher G
Liver Int; 2019 Dec; 39(12):2317-2329. PubMed ID: 31436362
[TBL] [Abstract][Full Text] [Related]
3. Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD.
Targher G; Mantovani A; Alisi A; Mosca A; Panera N; Byrne CD; Nobili V
Hepatology; 2019 Jul; 70(1):142-153. PubMed ID: 30912854
[TBL] [Abstract][Full Text] [Related]
4. PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels.
Sun DQ; Zheng KI; Xu G; Ma HL; Zhang HY; Pan XY; Zhu PW; Wang XD; Targher G; Byrne CD; Chen YP; Yuan WJ; Zheng MH
Liver Int; 2020 Jan; 40(1):107-119. PubMed ID: 31519069
[TBL] [Abstract][Full Text] [Related]
5. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
[TBL] [Abstract][Full Text] [Related]
6.
Li G; Tang LJ; Zhu PW; Huang OY; Rios RS; Zheng KI; Chen SD; Ma HL; Targher G; Byrne CD; Pan XY; Zheng MH
J Clin Transl Hepatol; 2022 Jun; 10(3):439-448. PubMed ID: 35836754
[TBL] [Abstract][Full Text] [Related]
7. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.
Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M
J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251
[TBL] [Abstract][Full Text] [Related]
8. Development of hepatocellular carcinoma in Japanese patients with biopsy-proven non-alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression.
Seko Y; Sumida Y; Tanaka S; Mori K; Taketani H; Ishiba H; Hara T; Okajima A; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Kanemasa K; Yasui K; Imai S; Shimada K; Itoh Y
Hepatol Res; 2017 Oct; 47(11):1083-1092. PubMed ID: 27862719
[TBL] [Abstract][Full Text] [Related]
9. Pediatric non-alcoholic fatty liver disease and kidney function: Effect of
Di Sessa A; Umano GR; Cirillo G; Passaro AP; Verde V; Cozzolino D; Guarino S; Marzuillo P; Miraglia Del Giudice E
World J Gastroenterol; 2020 Sep; 26(36):5474-5483. PubMed ID: 33024398
[TBL] [Abstract][Full Text] [Related]
10. Association between PNPLA3 rs738409 variant and 5-year estimated glomerular filtration rate decline in post-menopausal women with type 2 diabetes: A panel-data analysis.
Mantovani A; Zusi C; Csermely A; Taverna A; Cappelli D; Pagani M; Valenti L; Maffeis C; Targher G
Nutr Metab Cardiovasc Dis; 2023 May; 33(5):1093-1097. PubMed ID: 37208069
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of Serum Procollagen III N-Terminal Peptide for Liver Fibrosis in Infantile Cholestasis.
Wang Y; Pan W; Zhao D; Chen Y; Chen X; Xia H
Front Pediatr; 2020; 8():131. PubMed ID: 32296668
[No Abstract] [Full Text] [Related]
12. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea.
Lee SS; Byoun YS; Jeong SH; Woo BH; Jang ES; Kim JW; Kim HY
Dig Dis Sci; 2014 Dec; 59(12):2967-74. PubMed ID: 25069572
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease.
Grove JI; Thiagarajan P; Astbury S; Harris R; Delahooke T; Guha IN; Aithal GP
Liver Int; 2018 Oct; 38(10):1832-1838. PubMed ID: 29493856
[TBL] [Abstract][Full Text] [Related]
14. Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease.
Mantovani A; Zusi C; Sani E; Colecchia A; Lippi G; Zaza GL; Valenti L; Byrne CD; Maffeis C; Bonora E; Targher G
Diabetes Metab; 2019 Oct; 45(5):480-487. PubMed ID: 30763699
[TBL] [Abstract][Full Text] [Related]
15. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.
Paternostro R; Staufer K; Traussnigg S; Stättermayer AF; Halilbasic E; Keritam O; Meyer EL; Stift J; Wrba F; Sipos B; Canbay A; Schlattjan M; Aigner E; Datz C; Stickel F; Schafmayer C; Hampe J; Buch S; Prager G; Munda P; Mandorfer M; Ferenci P; Trauner M
Hepatol Int; 2021 Aug; 15(4):922-933. PubMed ID: 34076851
[TBL] [Abstract][Full Text] [Related]
17. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.
Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571
[TBL] [Abstract][Full Text] [Related]
18. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid from patients with pulmonary fibrosis.
Milman N; Kristensen MS; Bentsen K
APMIS; 1995 Oct; 103(10):749-54. PubMed ID: 8534435
[TBL] [Abstract][Full Text] [Related]
20. Quantitative digital pathology reveals association of cell-specific
Sandhu B; Perez Matos MC; Tran S; Zhong A; Csizmadia E; Kim M; Herman MA; Nasser I; Lai M; Jiang ZG
JHEP Rep; 2019 Sep; 1(3):199-202. PubMed ID: 32039370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]